Pharmaceutical Executive September 13, 2024
The latest news for pharma industry insiders.
AI Adoption for Clinical Trial Design, Planning
An overview of the advantages of implementing AI into clinical development and the obstacles that prevent its widespread adoption.
Comparing Biologics and Biosimilars
Sophia Humphreys, PharmD, MHA, BCBBS, discusses the key differences between biologics and biosimilars.
OpenAI’s Fund-Raising Talks Could Value Company at $150 Billion
The San Francisco start-up hopes to raise $6.5 billion as part of an aggressive push for more investment.
Dr.Evidence Unveils Major Enhancements to AI-enabled...
Today's Sponsors
Today's Sponsor